MPR retweeted
A joint venture has been formed between @charlottesweb and @AJNABiosciences , a subsidiary of @BATplc, to pursue FDA approval for a new botanical hemp product designed to address a neurological condition. bit.ly/3Op0Epc
MPR retweeted
.@HaymarketMedNet is activating its endocannabinoid system with the all-new AJEM, providing clinicians with peer-reviewed research, resources & educational tools to help guide patients in informed decision-making on cannabinoid-based therapies. endocannabinoidmedicine.com/
MPR retweeted
Future randomized clinical trials will further establish the prerequisites for less intensive and personalized treatment in SAB patients
Ongoing RCTs:
SAB7
The SAFE-trial
@snap_trial
Completed RCTs not published:
SABATO
#IDTwitter #MedEd
🆕️⚡️⚡️ @VanceFowler5
Redefining Staphylococcus aureus bacteremia: a structured approach guiding diagnostic and therapeutic management
cc @JonathanRyderMD @BrentFooter @syctong
#IDTwitter
journalofinfection.com/artic…
MPR retweeted
What is the efficacy & safety of guanfacine(GNF) to wean dexmedetomidine(DEX) in ICU pts?💊😴
💊DEX successfully weaned in 58% of pts w/in 48 h of GNF initiation
💊Median GNF dose 1.5 mg/day
💊Minimal withdrawal or adverse effects
#NeuroICU #PharmICU
journals.lww.com/ccejournal/…
MPR retweeted
The new @ClinicalPainAdv offers answers to your toughest questions, along with the latest news, treatment updates, and clinical tools to help you make informed decisions. We’re more than just a resource—we’re your Advisor. clinicalpainadvisor.com/gene…
MPR retweeted
Any reports of patients not being able to receive their medications and maintain that continuity of their care is very concerning for us as @pharmacists. #TwitteRx
Thanks to @Jamie_Ducharme at @TIME for covering this important issue
time.com/6194179/abortion-re…
MPR retweeted
Rates of maternal mortality and existing health disparities will increase with the overturning of #RoeVWade, experts say. @MGHMedicine @acog @harvardmed @BrighamWomens #AbortionIsHealthcare fal.cn/3pJm9
MPR retweeted
Join Keynote speaker @ALRodriguez0614 at the [CE Approved] 2022 #ONASummit as she kicks off day 1 with a conversation centered on the benefits and advantages of intra-professional collaboration within the world of oncology nursing. Register for FREE now! fal.cn/3ms0y
MPR retweeted
Welcome to Optometry Advisor, your new go-to source for #optometry news and clinical updates from the Haymarket Medical Network! optometryadvisor.com/
ALT Optometry Advisor: Optometry News and Clinical Updates
MPR retweeted
Updates #COVID #vaccine table with new information in peach. #covidー19 #covid19vaccine #publichealth #TwitteRx #COVID19 – at Tucson, AZ
MPR retweeted
Catheter-related bloodstream infections (CRBSIs) account for around 70% of all health care associated bloodstream infections. New trial indicates that 7-day replacement of infusion sets is safe, with resultant cost and workload reductions. hubs.ly/H0LsQyl0
MPR retweeted
Wow💥💥
BinaxNOW: What You Need to Know
A step-by-step video guide to conducting a BinaxNOW Self Test in the comfort of your own home abbott.com/corpnewsroom/diag…
MPR retweeted
Study Finds 1 in 10 Healthcare Workers with Mild COVID Have Lasting Symptoms directorsblog.nih.gov/2021/0… – at Tucson, AZ
MPR retweeted
💥💥COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets💥💥
EMA confirms overall benefit-risk remains positive
At its meeting of 20 April 2021. ema.europa.eu/en/news/covid-…
MPR retweeted
💥Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected with #COVID19 💥
ox.ac.uk/news/2021-04-19-hum…
MPR retweeted
IN PRESS: The authors explore potential policy solutions to improve community pharmacy working conditions and patient safety. @JBealPharmD
#communityPharmacy #patientSafety #TwitteRx #pharmacists
japha.org/article/S1544-3191…
MPR retweeted
This study challenges IDSA recommendations to continue antibiotics for a minimum of 5 days, even if the patient has reached clinical stability before 5 days.
Is it a practice changing!
Will the next @IDSAInfo guidelines be updated to a minimum of 3 days @BradSpellberg
NEW💥🔥💥 @TheLancet @aurdinh
PTC RCT 16 🇫🇷 centers >700 patients
Among hospitalized patients with CAP who met clinical stability criteria, discontinuing β-lactam treatment after 3 days was non-inferior to 8 days of treatment
#IDTwitter #Shorterisbetter thelancet.com/journals/lance…
MPR retweeted
💥Excellent Summary💥 @NEJM
Results on SARS-CoV-2 Vaccine Trial Efficacy and Viral Neutralization of the B.1.1.7, P.1, and 501Y.V2 Variants, as Compared with Preexisting Variants.
With regard to escape from vaccine-induced immunity
nejm.org/doi/full/10.1056/NE…
